Moderna Says COVID-19 Vaccine 96% Effective in Teens

Headline Roundup May 6th, 2021

Moderna released results of its trials for the COVID-19 vaccine in teens age 12-17, saying it is 96% effective against the virus. The trial involved 3,235 participants; among those, 12 COVID-19 cases were recorded beginning 14 days after the first dose. The company said it has not identified any serious safety concerns to date. This comes after Pfizer and BioNTech last month found their COVID-19 vaccine to be 100% effective among ages 12-15. The Food and Drug Administration (FDA) is expected to give emergency use authorization for the Pfizer vaccine to be used among adolescents in the next week.

The story received coverage from across the political spectrum. Coverage from left and center-rated outlets tended to focus on the details of the trial; some right-rated outlets framed the news in the context of a return to in-person schooling in the fall.

Moderna Says COVID-19 Vaccine 96% Effective in Teens

From the Left
13320

Moderna's COVID-19 vaccine is 96% effective in teenagers 12- to 17-years-old, the drugmaker said Thursday. The company announced results of the Phase 2 trial in reporting first-quarter earnings. Its vaccine generated $1.7 billion in revenue in its fiscal first quarter.

Evidence that Moderna's vaccine is effective in teens comes as rival Pfizer is expected to receive federal authorization by early next week to use its COVID-19 vaccine in adolescents. Federal approval of one or more vaccines against the disease could enable many American middle and high school students to be...

Read full story
From the Center
1631

Moderna on Thursday released the results of its COVID-19 vaccine trials for those aged 12 to 17, reporting it 96 percent effective against the virus.

The vaccine manufacturer said its trial, involving 3,235 participants, recorded 12 COVID-19 cases that emerged beginning 14 days after the first dose. The company said it had not identified any serious safety concerns to date.

The results of the adolescent trial come as the Food and Drug Administration (FDA) is expected to give emergency use authorization for the Pfizer-BioNTech vaccine to be used...

Read full story
From the Right
13320

Moderna has claimed that its COVID-19 vaccine is effective up to 96% in teens aged 12 to 17, presenting a major boost to hopes of a full-time return to in-person learning in the fall.

The announcement is just one of several major developments Moderna revealed in its Q1 2021 Business Update.

Parents and students alike have complained about the issues faced by studying remotely, with some concerns that students were falling behind due to remote learning and may never catch up again.

Read full story